The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given 'as needed' in mild asthma: study protocols for two randomised controlled trials.

Paul O'Byrne, J Mark Fitzgerald, Nan Shan Zhong, Eric D Bateman, Peter J Barnes, Christina Keen, Gun Almqvist, Kristine Pemberton, Carin Jorup, Stefan Ivanov, Helen K Reddel

Division of Immunology, Immunity to Infection and Respiratory Medicine

Research output: Contribution to journal › Article › peer-review

1 results
- Title
- Start date(ascending)

The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given ‘as needed’ in mild asthma: study protocols for two randomised controlled trials
O'Byrne, P. (Creator), Fitzgerald, J. (Creator), Zhong, N. S. (Creator), Bateman, E. D. (Creator), Barnes, P. J. (Creator), Keen, C. (Creator), Almqvist, G. (Creator), Pemberton, K. (Creator), Jorup, C. (Creator), Ivanov, S. (Creator) & Reddel, H. K. (Creator), figshare , 10 Jan 2017
DOI: 10.6084/m9.figshare.c.3661703
Dataset

The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given 'as needed' in mild asthma: study protocols for two randomised controlled trials.

Datasets

Search results

The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given ‘as needed’ in mild asthma: study protocols for two randomised controlled trials